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Although the association constant between an antibody and a labeled ligand, K*, can be easily determined experimentally through a Scatchard analysis, the value of K can only be calculated indirectly because the unlabeled analyte does not usually generate a measurable signal. In this study, the association constant, K, between the monoclonal antibody and progesterone is estimated by using the massaction model described above and experimental data. (1) The materials and methods, the characterization of the monoclonal antibody (clone BQ.1), and the evaluation of the immunoassay have been described previously (14) . The labeled derivative, iodinated progesterone lia-hemisuc- (2) cinyl tyrosine methyl ester (P-TME), was purified by HPLC (14) , so that it did not contain any unlabeled ligand.4 Dose-response curves for radioiminunoassays of progesterone and progesterone lia-hemisuccinate (P11-HS) were obtained by using two different methods to separate free from antibody-bound antigen: (a) second-antibody separation with sheep anti-mouse IgG, or (b) adsorption of the free antigen on dextran-coated charcoal (14) . Note that we subtracted the nonspecifically bound radioactivity from each data point of the dose-response curve.
Materials and Methods

Results and Discussion
We used monoclonal antibodies to verify the theoretical model because they constitute a single class of well-defined, uniform binding proteins; i.e., they possess a single population of binding sites. The association constant, K*, for the monoclonal antibody toward the radiolabeled progesterone derivative, P-TME, was estimated from Scatchard plots. Averaging six determinations resulted in a value of 1.1 (SD 0.42) x 1011 L mol' (14) . Scatchard plots were also used 4Nonstandard abbreviations: P-TME, iodinated progesterone lla-hemisuccinyl tyrosinemethyl ester; P11-HS, progesterone lla-hemisuccinate; and ED50, effective dose of (unlabeled) ligand that displaces 50% of (labeled) derivative. (13) . Here, we describe our findings on the bridging-group recognition by a high-affinity anti-progesterone monoclosal antibody (14) . We also offer a simple method by which the affinity constant of an antibody toward an unlabeled
Ligand can be estimated from typical radioimmunoassay standard curves. This method is compared with the cur--ently used methods of Cheng-Prusoff and LIGAND.
lllodeI for Radlolmmunoassay
The principle of many immunoassays is based on the ompetition of labeled and unlabeled ligands for a fixed sumber of binding sites of the specific binder (15) :
[PI[Q1 p* + Q Qp*, K* = [QPI vhere P is the unlabeled ligand, P'' is the labeled ligand, Q 5 the antibody (binder), and K and K* are the association onstants for the two reactions. The initial concentrations of P and P" are symbolized by and p", respectively. The symbol q is used to represent the otal concentration of binding sites in the assay (i.e., q is wice the concentration of antibody), and [Q] refers to the oncentration of unoccupied binding sites at equilibrium. n this study, it is assumed that the antibody possesses mivalent, independent, and equivalent binding sites.
The maximum bound labeled ligand (i.e., the B0 value) is alculated as [QP*] when the concentration of the unlaeled ligand is equal to zero. Taking into account the nasa-balance equations for binding sites and labeled hgnd, the following quadratic equation can be derived from quation 2: to obtain the concentration of the binding sites in the assay, which was found to equal 1.3 x 10-' mollL. The association constant, K, for the antibody toward the two unlabeled compounds, progesterone and P11-HS, was estimated from dose--response curves. Two different sets of K were obtained, depending on whether the radioimmunoassay procedure involved separation by second antibody (sheep anti-mouse IgG) or dextran-coated charcoal (14) . The results from this study are summarized in Table 1 , along with the concentration of P-TME (p*) in the assay mixture (calculated from radioactivity measurements of chromatographically purified P-TME) and the experimentally obtained ED50 (estimated graphically from the dose.-response curves).
As Table 1 shows, the experimental determination of the association constants gives similar estimates for both progesterone and P11-HS, independent of whether the free ligands were separated with a second antibody or with charcoal. The higher affinity of the monoclonal antibody for the hemisuccinate derivative than for the unmodified steroid indicates that the bridging group of the steroid derivative is involved in the recognition by the antibody. This is not unexpected because the mice used were immunized with a progesterone-protein conjugate (Figure 1 ) that conmined the same chemical link (i.e., the hemisuccinyl group) between the hapten and the protein (14) . The affinity of the monoclonal antibody for P-TME (1.1 x 1011 L moh1) is higher than its affinities for progesterone and P11-115.
We investigated the estimated binding constants with a theoretical model that predicts expected dose-response curves as a function of the binding constants between the immunoghobulin and its specific labeled and unlabeled ligands (16) . To this end, dose-response curves for progesterone were simulated by using the estimated association constant K = 1.1 x 1010 moh/L. Figure 2 shows a plot of the results for the experimentally obtained radioimmunoassay data (using a second-antibody separation procedure) and simulated curves based on values of K = 5.5 x iO and 2.2 x 1010 mol/L (one-half and twice the estimated value). Note the very close correlation between the experimentally obtained data and the simulated dose-response curves.
A popular method for estimating K has been proposed by Cheng and Prusoff (11) , who use the following formula: hemisuccinate (P11-HS), the progesterone-bovine serum aIbumi (BSA) immunogen, and iodinated progesterone 11a-hemisuccin tyrosine methyl ester (P-TME)
found that the former provided estimates for the associa tion constants that substantially differed from the tru values (Table 2) . Munson and Rodbard used data fron dose-response curves for three unlabeled ligands, L1, L1 and L3, and used the same labeled ligand to generate a] three dose-response curves. K1, K2, and K3 are the corre spending association constants between the binder am each unlabeled higand.
We applied the method described here to the same set c data (from Figure 3 in reference 12) after correcting fo nonspecific binding (we assumed that the horizonta asymptote at the high-concentration end of the dose-re sponse curve corresponded to the value of the nonspecif binding).
As shown in Table 2 , our method is capable accurately estimating the association constants K1 and K
Our estimated value
for K3 is much better than thi obtained by the Cheng-Prusoff method and is close to ti one predicted by LIGAND. We attribute this to the fact tha unlike the Cheng-Prusoff method, the theoretical approai described in this article is based on an exact mathematic model, as is the program LIGAND. The difference betwee our program and the model used for LIGAND is that Munsc and Rodbard used extensive programming to fit the original data by a nonlinear least-squares regression analysis (12) . Consequently, LIGAND can also provide statistical information about the estimated association constants. An advantage of our approach is that only three computational steps are required, which is a relatively simple way to obtain estimates of K: indeed, this calculation can be performed on a pocket calculator.
In conclusion, we propose a mass-action model that enables calculation of the association constant between a specific binding protein and its corresponding unlabeled or labeled ligand. Thus, affinity constants for the two chemically different species can be derived simply from the dose-response curves, which are usually readily available.
This study also demonstrates that there is some recognition by the antibody of the bridge between the native antigen and a derivative that can be radiolabeled.
